tert-Butyl 1-amino-3,6,9,12,15,18-hexaoxahenicosan-21-oate
95%
- Product Code: 39908
CAS:
1286281-32-0
Molecular Weight: | 409.52 g./mol | Molecular Formula: | C₁₉H₃₉NO₈ |
---|---|---|---|
EC Number: | MDL Number: | MFCD13184944 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, protected from light, stored in an inert gas |
Product Description:
This chemical is primarily utilized in the synthesis of complex organic molecules, particularly in the development of drug delivery systems. Its structure, featuring multiple ether linkages and an ester group, makes it suitable for creating biocompatible and water-soluble compounds. It is often employed in the design of prodrugs, where it can enhance the solubility and stability of active pharmaceutical ingredients. Additionally, it serves as a key intermediate in the preparation of polyethylene glycol (PEG)-based conjugates, which are widely used in targeted drug delivery and bioconjugation strategies to improve therapeutic efficacy and reduce side effects.
Product Specification:
Test | Specification |
---|---|
APPEARANCE | colourless to yellow liquid |
PURITY | 94.5-100 |
Infrared spectrum | Conforms to Structure |
NMR | Conforms to Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.250 | 10-20 days | £275.02 |
+
-
|
1.000 | 10-20 days | £550.27 |
+
-
|
tert-Butyl 1-amino-3,6,9,12,15,18-hexaoxahenicosan-21-oate
This chemical is primarily utilized in the synthesis of complex organic molecules, particularly in the development of drug delivery systems. Its structure, featuring multiple ether linkages and an ester group, makes it suitable for creating biocompatible and water-soluble compounds. It is often employed in the design of prodrugs, where it can enhance the solubility and stability of active pharmaceutical ingredients. Additionally, it serves as a key intermediate in the preparation of polyethylene glycol (PEG)-based conjugates, which are widely used in targeted drug delivery and bioconjugation strategies to improve therapeutic efficacy and reduce side effects.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :